Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001757072-25-000008
Filing Date
2025-11-12
Accepted
2025-11-12 16:16:43
Documents
1
Period of Report
2025-11-07

Document Format Files

Seq Description Document Type Size
1 form4-11122025_091140.html 4  
1 form4-11122025_091140.xml 4 5549
  Complete submission text file 0001757072-25-000008.txt   6899
Mailing Address 450 EAST 29TH STREET NEW YORK NY 10016
Business Address
Carver Kyle (Reporting) CIK: 0001757072 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-42938 | Film No.: 251472989

Mailing Address 1841 PAGE MILL RD PALO ALTO CA 94304
Business Address 1841 PAGE MILL RD PALO ALTO CA 94304 (650) 223-7745
Evommune, Inc. (Issuer) CIK: 0002044725 (see all company filings)

EIN.: 850742575 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)